EUVIMEDEUVIMED entdecken
Crossref

Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following Surgery

Christine J O'Neill iD, Christopher W Rowe, Harriet Morris-Baguley, Melissa A Carlson, Sarah Leask, Tara Clinton-McHarg iD, Elizabeth Holliday, Elizabeth A Fradgley, Christine L Paul

Thyroid® · 2025-09 · 35 (9) · 1039-1051

DOI: 10.1089/thy.2025.0149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, online erschienen am 10.09.2025. Verfasst von Christine J O'Neill und 8 weiteren Autor:innen. Beteiligte Einrichtung: Surgical Services, John Hunter Hospital, Newcastle, New South Wales, Australia. Hauptthemen laut MEDLINE: Quality of Life, Thyroid Neoplasms, Cancer Survivors, Thyroidectomy. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 81 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thyroid cancer survivors may experience significant health-related quality-of-life (HRQoL) detriments. Currently available HRQoL survey tools, used in isolation, can be insensitive to change over time and may incompletely assess thyroid cancer-specific symptoms and fear of cancer recurrence. This study aimed to measure the trajectory of HRQoL changes in thyroid cancer survivors using repeated measures, comparing commonly used surveys, over the first 12–18 months following diagnosis.

Methods

A prospective longitudinal cohort study recruited all patients with newly diagnosed thyroid cancer (excluding low-risk papillary thyroid microcarcinoma and anaplastic thyroid cancer) from a mixed metropolitan and regional health district (public and private). Patients were invited to complete Short Form-12 (SF-12), EORTC-QLQ-C30, Thyroid Cancer Quality of Life (ThyCaQoL) Survey, City of Hope–Thyroid Version, and Assessment of Survivor Concerns surveys postoperatively, and at 3, 6, and 12 months. Responses were assessed for changes over time, and multivariable analysis was used to identify variables associated with outcomes at follow-up.

Results

Between January 2021 and June 2023, 111 patients completed surveys at a minimum of one time point (response rate 59%). Most were female (72%), mean age 55 years, 56% metropolitan, 56% privately insured, 55% American Thyroid Association low-risk differentiated thyroid cancer. Treatment included surgery (total thyroidectomy 49%, two-stage thyroidectomy 24%, lobectomy 25%, active surveillance 2%); 58% received radioactive iodine ablation. At the completion of the study, 82% were euthyroid and 92% disease-free. At all time points, SF-12 physical and mental component scores (PCS and MCS), remained below normative population values (>12 months; mean PCS = 39.4, mean MCS = 46.7, normative = 50). MCS showed more consistent improvement over the first year following thyroid cancer diagnosis (global p = 0.03). ThyCaQoL surveys identified improvement in voice and scar symptoms ( p < 0.01 each), but distress regarding neuromuscular ( p < 0.01), sensory symptoms ( p = 0.01), and weight gain ( p = 0.04) worsened over the course of the study. Fear of cancer recurrence was common and persisted over time.

Conclusion

A year after diagnosis, thyroid cancer survivors have persisting HRQoL deficits with some symptoms worsening over time. As part of follow-up care, clinicians should specifically inquire about persistent symptoms that could affect HRQoL. Supportive care interventions for those with persistent HRQoL deficits are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeThyroid NeoplasmsCancer SurvivorsThyroidectomyHumansFemaleMaleMiddle AgedProspective StudiesAdultLongitudinal StudiesAgedSurveys and Questionnaires

Stichwörter der Autor:innen

cancer survivorshipfear of cancer recurrencehealth-related quality of lifepatient reported outcome measuresthyroid cancerthyroidectomy

Autor:innen und Institutionen

  • Surgical Services, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • School of Medicine and Public Health, University of Newcastle, Newcastle, New South Wales, Australia.
  • Hunter Medical Research Institute, Newcastle, New South Wales, Australia.
  • Department of Endocrinology, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Christine J O'Neill, Tara Clinton-McHarg

Zitieren

APA

O'Neill, C. J., Rowe, C. W., Morris-Baguley, H., Carlson, M. A., Leask, S., Clinton-McHarg, T., Holliday, E., Fradgley, E. A., & Paul, C. L. (2025). Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following Surgery. Thyroid®, 35(9), 1039-1051. https://doi.org/10.1089/thy.2025.0149

Vancouver

O'Neill CJ, Rowe CW, Morris-Baguley H, Carlson MA, Leask S, Clinton-McHarg T, et al. Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following Surgery. Thyroid®. 2025;35(9):1039-1051. doi:10.1089/thy.2025.0149

BibTeX
@article{ONeill2025,
  author = {O'Neill, Christine J and Rowe, Christopher W and Morris-Baguley, Harriet and Carlson, Melissa A and Leask, Sarah and Clinton-McHarg, Tara and Holliday, Elizabeth and Fradgley, Elizabeth A and Paul, Christine L},
  title = {Thyroid Cancer Survivors Experience Persistent Symptoms and Health-Related Quality-of-Life Deficits 12 Months Following Surgery},
  journal = {Thyroid®},
  year = {2025},
  volume = {35},
  number = {9},
  pages = {1039--1051},
  doi = {10.1089/thy.2025.0149}
}
Kostenlos starten →